Dr Haiquan Chen: clinical significance of RET fusion gene for patients with NSCLC

Gelijkaardige items

• Minshan Chen: combination of TACE and RFA can improve the treatment of HCC
  door: Feng, Zhihua
  Gepubliceerd in: (2013)
• Gavreto, RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions
  Gepubliceerd in: (2020)
• Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations
  door: Huijuan Wang, et al.
  Gepubliceerd in: (2020-01-01)
• Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion.
  door: Piotrowska, Zofia, et al.
  Gepubliceerd in: (2018)
• Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Gene
  door: Qiu, Zhixin, et al.
  Gepubliceerd in: (2020)